UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prevalence, pathophysiology and management of itch in epidermolysis bullosa

British journal of dermatology (1951), 2021-05, Vol.184 (5), p.816-825

2021

Volltextzugriff (PDF)

Fibroblast cell therapy enhances initial healing in recessive dystrophic epidermolysis bullosa wounds: results of a randomized, vehicle-controlled trial

British journal of dermatology (1951), 2013-11, Vol.169 (5), p.1025-1033

2013

Volltextzugriff (PDF)

Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility

British journal of dermatology (1951), 2020-10, Vol.183 (4), p.614-627

2020

Volltextzugriff (PDF)

Enduring support for the case report

British journal of dermatology (1951), 2019-09, Vol.181 (3), p.429-430

Mellerio, J.E.

2019

Volltextzugriff (PDF)

Potential therapeutic targeting of inflammation in epidermolysis bullosa simplex

British journal of dermatology (1951), 2019-02, Vol.180 (2), p.258-260

Mellerio, J.E.

2019

Volltextzugriff (PDF)

445 Does tyrosine and serine phosphorylation of STAT3 drive cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa?

Journal of investigative dermatology, 2022-12, Vol.142 (12), p.S257-S257

2022

Volltextzugriff (PDF)

The psychological functioning of children with epidermolysis bullosa and its relationship with specific aspects of disease

British journal of dermatology (1951), 2020-03, Vol.182 (3), p.789-790

2020

Volltextzugriff (PDF)

Genotype–phenotype correlation in a large English cohort of patients with autosomal recessive ichthyosis

British journal of dermatology (1951), 2020-03, Vol.182 (3), p.729-737

2020

Volltextzugriff (PDF)

Neonatal aggressive systemic mastocytosis

British journal of dermatology (1951), 2017-11, Vol.177 (5), p.1167-1168

Mellerio, J.E.

2017

Volltextzugriff (PDF)

Management of cutaneous squamous cell carcinoma in patients with epidermolysis bullosa: best clinical practice guidelines

British journal of dermatology (1951), 2016-01, Vol.174 (1), p.56-67

2016

Volltextzugriff (PDF)

EBGene trial: patient preselection outcomes for the European GENEGRAFT ex vivo phase I/II gene therapy trial for recessive dystrophic epidermolysis bullosa

British journal of dermatology (1951), 2020-03, Vol.182 (3), p.794-797

2020

Volltextzugriff (PDF)

Desmosomal genodermatoses

British journal of dermatology (1951), 2012-01, Vol.166 (1), p.36-45

2012

Volltextzugriff (PDF)

Practical management of epidermolysis bullosa: consensus clinical position statement from the European Reference Network for Rare Skin Diseases

Journal of the European Academy of Dermatology and Venereology, 2021-12, Vol.35 (12), p.2349-2360

2021

Volltextzugriff (PDF)

Heterogeneous addiction to transforming growth factor‐beta signalling in recessive dystrophic epidermolysis bullosa‐associated cutaneous squamous cell carcinoma

British journal of dermatology (1951), 2021-04, Vol.184 (4), p.697-708

2021

Volltextzugriff (PDF)

The management of general and disease specific ENT problems in children with Epidermolysis Bullosa—A retrospective case note review

International journal of pediatric otorhinolaryngology, 2007-03, Vol.71 (3), p.385-391

2007

Volltextzugriff (PDF)

Wound healing in epidermolysis bullosa

British journal of dermatology (1951), 2017-11, Vol.177 (5), p.e193-e195

2017

Volltextzugriff (PDF)

Recommendations on pregnancy, childbirth and aftercare in epidermolysis bullosa: a consensus‐based guideline

British journal of dermatology (1951), 2022-04, Vol.186 (4), p.620-632

2022

Volltextzugriff (PDF)

736 Intravenous allogeneic mesenchymal stromal cell therapy in adults with recessive dystrophic epidermolysis bullosa is safe, improves quality of life and reduces itch

Journal of investigative dermatology, 2018-05, Vol.138 (5), p.S125-S125

2018

Volltextzugriff (PDF)

157 Comparing adenine base editing and CRISPR-Cas9 gene editing strategies to correct recurrent mutations in RDEB primary fibroblasts

Journal of investigative dermatology, 2021-10, Vol.141 (10), p.S175-S175

2021

Volltextzugriff (PDF)

Whole-exome sequencing improves mutation detection in a diagnostic epidermolysis bullosa laboratory

British journal of dermatology (1951), 2015-01, Vol.172 (1), p.94-100

2015

Volltextzugriff (PDF)

Foot care in epidermolysis bullosa: evidence‐based guideline

British journal of dermatology (1951), 2020-03, Vol.182 (3), p.593-604

2020

Volltextzugriff (PDF)

069 Multi-omic analyses highlight key molecular pathways in dystrophic epidermolysis bullosa pruriginosa

Journal of investigative dermatology, 2021-10, Vol.141 (10), p.S160-S160

2021

Volltextzugriff (PDF)

278 Generation and clinical application of gene modified autologous epidermal sheets in Netherton syndrome – lessons learned from a phase 1 trial

Journal of investigative dermatology, 2019-09, Vol.139 (9), p.S262-S262

2019

Volltextzugriff (PDF)

Characteristics of children with Netherton syndrome: a review of 21 patients

Journal of the European Academy of Dermatology and Venereology, 2021-07, Vol.35 (7), p.e466-e469

2021

Volltextzugriff (PDF)

Creating new guidelines on how best to treat foot symptoms in people with EB

British journal of dermatology (1951), 2020-03, Vol.182 (3), p.e89-e89

2020

Volltextzugriff (PDF)

1 – 25 von 75

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(69)
Mit Volltextzugriff
(74)

Publikationsform

Sprache

Englisch
(75)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prevalence, pathophysiology and management of itch in epidermolysis bullosa

Fibroblast cell therapy enhances initial healing in recessive dystrophic epidermolysis bullosa wounds: results of a randomized, vehicle-controlled trial

Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility

Enduring support for the case report

Potential therapeutic targeting of inflammation in epidermolysis bullosa simplex

445 Does tyrosine and serine phosphorylation of STAT3 drive cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa?

The psychological functioning of children with epidermolysis bullosa and its relationship with specific aspects of disease

Genotype–phenotype correlation in a large English cohort of patients with autosomal recessive ichthyosis

Neonatal aggressive systemic mastocytosis

Management of cutaneous squamous cell carcinoma in patients with epidermolysis bullosa: best clinical practice guidelines

EBGene trial: patient preselection outcomes for the European GENEGRAFT ex vivo phase I/II gene therapy trial for recessive dystrophic epidermolysis bullosa

Desmosomal genodermatoses

Practical management of epidermolysis bullosa: consensus clinical position statement from the European Reference Network for Rare Skin Diseases

Heterogeneous addiction to transforming growth factor‐beta signalling in recessive dystrophic epidermolysis bullosa‐associated cutaneous squamous cell carcinoma

The management of general and disease specific ENT problems in children with Epidermolysis Bullosa—A retrospective case note review

Wound healing in epidermolysis bullosa

Recommendations on pregnancy, childbirth and aftercare in epidermolysis bullosa: a consensus‐based guideline

736 Intravenous allogeneic mesenchymal stromal cell therapy in adults with recessive dystrophic epidermolysis bullosa is safe, improves quality of life and reduces itch

157 Comparing adenine base editing and CRISPR-Cas9 gene editing strategies to correct recurrent mutations in RDEB primary fibroblasts

Whole-exome sequencing improves mutation detection in a diagnostic epidermolysis bullosa laboratory

Foot care in epidermolysis bullosa: evidence‐based guideline

069 Multi-omic analyses highlight key molecular pathways in dystrophic epidermolysis bullosa pruriginosa

278 Generation and clinical application of gene modified autologous epidermal sheets in Netherton syndrome – lessons learned from a phase 1 trial

Characteristics of children with Netherton syndrome: a review of 21 patients

Creating new guidelines on how best to treat foot symptoms in people with EB

Suchergebnisse filtern